YTTRIUM Y-90 LABETUZUMAB TETRAXETAN
UNII QTV68S4T5M

Substance Identification & Data

This profile provides standardized clinical and technical data for Yttrium Y-90 Labetuzumab Tetraxetan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QTV68S4T5M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 501423-30-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

QTV68S4T5M

CAS Registry Number

501423-30-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

YTTRIUM Y-90 LABETUZUMAB TETRAXETAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C152940

National Cancer Institute reference terminology for clinical and research data.

USAN ID

PP-26

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Yttrium Y-90 Labetuzumab Tetraxetan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.